Rationalizing the clinical use of frozen plasma

Pinkerton, Peter H.; Callum, Jeannie L.
July 2010
CMAJ: Canadian Medical Association Journal;7/13/2010, Vol. 182 Issue 10, p1019
Academic Journal
The article offers the authors' views on the clinical use of frozen plasma. The authors note that most of the use of frozen plasma lacks objective evidence to support its value and it contributes to the mortality and morbidity resulting from transfusion of blood components. They cite the studies in Canada showing that 45.0% and 47.6% of frozen plasma transfusions represented improper use. They also mention that more clinical trials are needed to determine the correct usage of frozen plasma.


Related Articles

  • Guidelines on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products.  // WHO Technical Report Series;2004, Issue 924, p150 

    Summarizes guidance on viral inactivation and removal procedures intended to assure the viral safety of human blood plasma products. Clinical trials to assess safety; Implementation in a manufacturing setting; Screening methods; Ultraviolet-C light irradiation; Pasteurized fresh frozen plasma;...

  • III. Fibrinogen concentrate: clinical reality and cautious Cochrane recommendation. Kozek-Langenecker, S.; Fries, D.; Spahn, D. R.; Zacharowski, K. // BJA: The British Journal of Anaesthesia;May2014, Vol. 112 Issue 5, p784 

    No abstract available.

  • Normal serum aminotransferase concentration and risk of mortality from liver diseases:prospective cohort study. Kim, Hyeon Chang; Nam, Chung Mo; Jee, Sun Ha; Hyub Han, Kwang; Kyu Oh, Dae; Suh, Il // BMJ: British Medical Journal (International Edition);4/24/2004, Vol. 328 Issue 7446, p983 

    Abstract Objective To examine the relation between the normal range of serum aminotransferase concentration and mortality from liver disease. Design Prospective cohort study. Setting Korea Medical Insurance Corporation study with eight years follow up. Participants 94,533 men and 47,522 women...

  • The expression and pathophysiological role of osteopontin in Graves' disease. Logie, James // Annals of Clinical Biochemistry;Jan2012, Vol. 49 Issue 1, p104 

    The article offers information on the study of the pathogenesis of Graves' disease (GD). It also offers the results on the clinical trials for serum osteopontin concentration and GD. The enzyme-linked immunosorbent assay was used to measure the serum from GD patients. It discusses quantitative...

  • Comparison of efficacy and safety of Cinacalcet versus Calcitriol in patients of secondary hyperparathyroidism in Indian population. Choulwar, Amol K.; Mungantiwar, Ashish A.; Chintamaneni, Meena // Journal of Pharmacy Research;2012, Vol. 5 Issue 1, p38 

    Treatment of secondary hyperparathyroidism with vitamin-D and calcium in patients receiving dialysis is often complicated by hypercalcemia and hyperphosphatemia, which may contribute to cardiovascular disease and adverse clinical outcomes. Calcimimetic agents (Cinacalcet) act on the...

  • Effect ofHelicobacter pyloriEradication in Patients with Chronic Idiopathic Thrombocytopenic Purpura–A Randomized Controlled Trial. Suzuki, Takayoshi; Matsushima, Masashi; Masui, Aya; Watanabe, Ken-ichi; Takagi, Atsushi; Ogawa, Yoshiaki; Shirai, Takayuki; Mine, Tetsuya // American Journal of Gastroenterology;Jun2005, Vol. 100 Issue 6, p1265 

    OBJECTIVE: Eradication ofHelicobacter pyloriwas reported to increase the platelet counts in someH. pylori-positive patients with chronic idiopathic thrombocytopenic purpura (cITP). However, the efficacy of the eradication was quite different according to the previous reports. To determine...

  • Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Weixin Hu; Chunbei Liu; Honglang Xie; Huiping Chen; Zhihong Liu; Leishi Li // Nephrology Dialysis Transplantation;Apr2008, Vol. 23 Issue 4, p1307 

    Objective. We performed a single-centre non-blinded clinical trial to compare the clinical efficacies of mycophenolate mofetil (MMF) and intermittent cyclophosphamide (CTX) pulse therapy as induction treatments in patients with antineutrophil cytoplasmic antibody (ANCA) vasculitis (AAV) and...

  • Tendon trouble.  // Mayo Clinic Health Letter;Mar2010, Vol. 28 Issue 3, p7 

    The article deals with the use of platelet-rich plasma (PRP) injections for the treatment of an ailing tendon tissue. It relates the process of deriving PRP and how PRP promotes injured tissue. It outlines the mechanisms by which PRP injections help in promoting tissue regeneration in...

  • Residents benefit from research.  // Hudson Valley Business Journal;06/04/2001, Vol. 12 Issue 6, p15 

    Focuses on how clinical trials have helped to reduce the mortality rate from heart disease in the United States. Examples of medical advances that have been made as a result of clinical trials; Hospitals in the Hudson Valley which participate in cardiac clinical trials; Role of interns and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics